1. In Vivo
  2. >>Leadership

Carlo Rivis: Know Your Own Value In Bringing Disruptive Innovation To Market

The Innovation Discovery CEO Has Made It His Role To Connect All The Dots In Delivering Novel Technology

 
• By Ashley Yeo

Entrepreneur Carlo Rivis, one of In Vivo’s Rising Leaders, brought his disruptive innovation approaches to in-silico trials and digital avatar developer Computational Life, and now he is doing the same at Innovation Discovery.

Connections

Before the COVID-19 lockdowns and social distancing measures put face-to-face business routines and conference attendance on hold, Carlo Rivis was a regular on the investor meeting circuit, building up awareness of the mathematical modeling technologies that he says will one day be a viable alternative to traditional clinical trials.

Computational Life is one of the few companies developing this technology, which uses software to simultaneously simulate the dynamics of the arterial and venous system, heart, microcirculation, pulmonary circulation and cerebrospinal fluid

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from In Vivo

With 75 Pipeline Candidates, TIL Therapies Gain Momentum in Solid Tumor Space

 
• By David Wild

Tumor infiltrating lymphocyte therapies show promise for solid tumors, with a first FDA approval, but face manufacturing and access challenges as development continues.

NewAmsterdam’s Davidson On Reviving “Failed” Drug Class To Fill Cardiovascular Treatment Gap

 
• By David Wild

After a string of high-profile failures by big pharma, Michael Davidson is positioning his company's CETP inhibitor as the next breakthrough in cardiovascular medicine. The body of data to support this position is growing.

Rising Leaders 2025: Flagship’s Jacob Rubens On Building The Next Generation Of Biotech

 
• By David Wild

Rising Leader Jacob Rubens, who has co-founded and led several Flagship companies and is now origination partner, believes aspiring leaders should follow their bliss.